Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
Olema Pharmaceuticals (OLMA) Ownership - Who Owns Olema Pharmaceuticals?
236 Followers
Olema Pharmaceuticals (OLMA) Ownership Overview
The ownership structure of Olema Pharmaceuticals (OLMA) stock is a mix of institutional, retail and individual investors. Approximately 81.46% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 18.54% is owned by Public Companies and Individual Investors.
0.00% Insiders
8.89% Mutual Funds
72.57% Other Institutional Investors
18.54% Public Companies and
Individual Investors
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 22, 2023 | Harmon Cyrus Director | Sold | $117740 |
| Nov 22, 2023 | Shane William Charles Kovacs Ch. Operating & Financial Off. | Sold | $269656 |
| Nov 22, 2023 | Myles David C. Ch. Discov. & Non Clin Dev Off | Sold | $196233 |
| Nov 22, 2023 | Bohen Sean President & Ceo,director | Sold | $824134 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2023 | Bought | $166403 | |
| Sep 30, 2023 | Bought | $8859050 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,654,384.00 | Institution | 3.02% | 21,358,097.44 | |
| 1,515,247.00 | Institution | 2.77% | 19,561,838.77 | |
| 1,277,716.00 | Institution | 2.33% | 16,495,313.56 | |
| 1,036,656.00 | Institution | 1.89% | 13,383,228.96 | |
| 717,332.00 | Institution | 1.31% | 9,260,756.12 | |
| 445,475.00 | Institution | 0.81% | 5,751,082.25 | |
| 397,041.78 | Institution | 0.72% | 5,125,809.43 | |
| 331,547.00 | Institution | 0.61% | 4,280,271.77 | |
| 260,483.00 | Institution | 0.48% | 3,362,835.53 | |
| 242,204.00 | Institution | 0.44% | 3,126,853.64 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,515,247.00 | Institution | 2.77% | 19,561,838.77 | |
| 1,277,716.00 | Institution | 2.33% | 16,495,313.56 | |
| 445,475.00 | Institution | 0.81% | 5,751,082.25 | |
| 331,547.00 | Institution | 0.61% | 4,280,271.77 | |
| 260,483.00 | Institution | 0.48% | 3,362,835.53 | |
| 220,220.00 | Institution | 0.40% | 2,843,040.20 | |
| 157,392.00 | Institution | 0.29% | 2,031,930.72 | |
| 118,774.00 | Institution | 0.22% | 1,533,372.34 | |
| 99,392.00 | Institution | 0.18% | 1,283,150.72 | |
| 83,656.00 | Institution | 0.15% | 1,079,998.96 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,022,226.00 | Institution | 1.87% | 13,585,384.00 | |
| 650,143.00 | Institution | 1.19% | 8,393,346.13 | |
| 527,566.00 | Institution | 0.96% | 7,011,352.00 | |
| 396,450.00 | Institution | 0.72% | 5,118,169.50 | |
| 232,678.00 | Institution | 0.42% | 3,280,791.15 | |
| 246,193.00 | Institution | 0.45% | 3,178,351.63 | |
| 83,361.00 | Institution | 0.15% | 1,271,255.25 | |
| 81,799.00 | Institution | 0.15% | 1,087,109.00 | |
| 60,327.00 | Institution | 0.11% | 919,986.75 | |
| 59,985.00 | Institution | 0.11% | 774,406.35 |
FAQ
Who Owns Olema Pharmaceuticals (OLMA)?
According to the latest TipRanks data, approximately 72.57% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 18.54% is held by retail investors.
What percentage of Olema Pharmaceuticals (OLMA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 72.57% of Olema Pharmaceuticals (OLMA) stock is held by institutional investors.
What percentage of Olema Pharmaceuticals (OLMA) stock is held by retail investors?
According to the latest TipRanks data, approximately 18.54% of Olema Pharmaceuticals (OLMA) stock is held by retail investors.
Who owns the most shares of Olema Pharmaceuticals (OLMA)?
Vanguard owns the most shares of Olema Pharmaceuticals (OLMA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.